A new study by researchers at the Georgia Institute of Technology suggests that the number of unique pocket sites where small molecule pharmaceutical compounds can bind to proteins is surprisingly small, meaning drug side effects may be impossible to avoid.
Studying a set of artificial proteins and comparing them to natural proteins, the team Continue reading
The U.S. Army Medical Research Acquisition Activity (USAMRAA) on behalf of the U.S. Army Medical Research and Materiel Command (USAMRMC) drug discovery and development mission, is conducting market research to obtain and acquire information on the availability of companies who have the capability to provide the oversight and management of a chemical repository and associated chemical information systems. Continue reading
An outbreak of wild poliovirus type 1 (WPV1) in the Horn of Africa has prompted urgent vaccination campaigns in the region, according to the World Health Organization.
A four-month-old girl near Dadaab, Kenya, developed symptoms at the end of April. Two healthy contacts of the child then tested positive for WPV1. They are the first laboratory confirmed cases Continue reading
The U.S. Department of Health and Human Services, Biomedical Advanced Research and Development Authority (BARDA) has entered into a collaborative agreement with Glaxo Smith Kline (GSK) to evaluate the efficacy and safety of the company’s portfolio of clinical stage antibacterial assets for treating hospital and biothreat infections.
The contract is unique in Continue reading
The U.S. Army Edgewood Chemical Biological Center (ECBC), on behalf of the Joint Science and Technology Office (JSTO), is leading an effort for the identification and assessment of technologies to support automated sensitive site exploitation (SSE). Continue reading
The U.S. Navy last month awarded Stemnion, Inc. a contract for continued therapeutic development efforts in support of the Naval Medical Research Center’s cellular combat wound initiative.
The initiative seeks to obtain a novel cellular wound healing technology that will accelerate and improve healing of a variety of combat-related Continue reading
Lawrence Livermore National Laboratory (LLNL), operated by the Lawrence Livermore National Security (LLNS), LLC under contract with the U.S. Department of Energy, is offering an opportunity to license intellectual property for a new Fast PCR Instrument technology for commercialization. Continue reading
Last month the Obama administration released the National Bioeconomy Blueprint, a broad plan to continue fostering research and development of medical therapies and devices, biofuels and next-generation biological manufacturing processes.
The report states that the current growth of the bioeconomy is due in large part to genetic engineering, DNA sequencing, and automated high-throughput manipulations of biomolecules. Expansion of emerging Continue reading